Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-05

Clinical Trial Update: Naloxegol and Opioid-induced Constipation [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for naloxegol investigating efficacy in opioid-induced constipation across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxegol (naloxegol)

Snippet

Sponsor: TriHealth Inc. | Conditions: Constipation, Constipation Drug Induced | Phase 2, Phase 3 | Status: UNKNOWN